Rovin Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
1,925
-2,256
| -54% | -$250K | 0.06% | 181 |
|
|
2025
Q1 | $468K | Sell |
4,181
-2,770
| -40% | -$310K | 0.15% | 111 |
|
|
2024
Q4 | $642K | Sell |
6,951
-2,708
| -28% | -$250K | 0.23% | 73 |
|
|
2024
Q3 | $810K | Buy |
9,659
+1,226
| +15% | +$103K | 0.3% | 69 |
|
|
2024
Q2 | $579K | Buy |
8,433
+966
| +13% | +$66.3K | 0.24% | 84 |
|
|
2024
Q1 | $547K | Sell |
7,467
-6
| -0.1% | -$440 | 0.22% | 90 |
|
|
2023
Q4 | $605K | Buy |
7,473
+1,765
| +31% | +$143K | 0.27% | 72 |
|
|
2023
Q3 | $428K | Buy |
5,708
+2,604
| +84% | +$195K | 0.2% | 74 |
|
|
2023
Q2 | $239K | Sell |
3,104
-456
| -13% | -$35.1K | 0.11% | 115 |
|
|
2023
Q1 | $295K | Sell |
3,560
-4,094
| -53% | -$339K | 0.14% | 101 |
|
|
2022
Q4 | $657K | Sell |
7,654
-1,257
| -14% | -$108K | 0.33% | 53 |
|
|
2022
Q3 | $550K | Sell |
8,911
-1,821
| -17% | -$112K | 0.32% | 49 |
|
|
2022
Q2 | $663K | Buy |
10,732
+544
| +5% | +$33.6K | 0.45% | 39 |
|
|
2022
Q1 | $606K | Buy |
10,188
+172
| +2% | +$10.2K | 0.32% | 48 |
|
|
2021
Q4 | $727K | Buy |
+10,016
| New | +$727K | 0.35% | 39 |
|